On April 8, Gelonghui reported that Shandong Jincheng Pharmaceutical Group (300233.SZ) stated on the investor interaction platform that the company's revenue from directly exporting synthetic biology products such as glutathione and SAM (S-adenosylmethionine) to the USA accounts for about 2%. According to the list of products exempt from Global tariffs and reciprocal tariffs released by the White House, and after preliminary communication with certain customers in the USA, the company's food-grade glutathione, SAM, and PQQ are included in the exemption list. The company will continue to monitor changes in tariff policies and maintain communication with customers.